Concepedia

Author

Ilaria Gandoglia

Ospedale Policlinico San MartinoORCID

Also Known As

I. Gandoglia, Ilaria Gandoglia

33

Publications

1K

Citations

15

H-Index

48

Concepts

All Affiliations

Ospedale Policlinico San MartinoUniversity of GenoaEnte Ospedaliero Ospedali GallieraAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaFondazione Istituto G. Giglio di Cefalù
IG

About

Ilaria Gandoglia is an author at Ospedale Policlinico San Martino specializing in medicine, pharmacotherapy, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

152

2

Immunology

2

2

31

3

Public Health

1

1

16

4

Epidemiology

1

1

16

5

Global Health

1

1

16

Ilaria Gandoglia

×

16

Publications

708

Citations

13

H-Index

YearCitations

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Maria Pia Sormani, Matilde Inglese, Irene Schiavetti,

EBioMedicine

2021

223

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

Maria Pia Sormani, Irene Schiavetti, Matilde Inglese,

EBioMedicine

2022

82

SARS-CoV-2 and Stroke Characteristics

Shima Shahjouei, Georgios Tsivgoulis, Ghasem Farahmand,

Stroke

2021

71

Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection

Andrea Assini, Ilaria Gandoglia, Valentina Damato,

European Journal of Neurology

2021

56

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori,

Neurotherapeutics

2019

51

Teriflunomide treatment reduces B cells in patients with MS

Ilaria Gandoglia, Federico Ivaldi, Alice Laroni,

Neurology Neuroimmunology & Neuroinflammation

2017

39

Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies

Maria Pia Sormani, Matilde Inglese, Irene Schiavetti,

SSRN Electronic Journal

2021

37

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

Alice Laroni, Claudio Giacomazzi, Luigi Grimaldi,

Journal of Neuroimmune Pharmacology

2012

34

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

Stefania Federica De Mercanti, Alessio Signori, Cinzia Cordioli,

Journal of the Neurological Sciences

2021

20

The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation

Erica Biassoni, Andrea Assini, Ilaria Gandoglia,

Journal of NeuroVirology

2021

17

Page 1